Radiation Therapy in a Case of Orbital Lymphoma

Molinaro, MA (2008) Radiation Therapy in a Case of Orbital Lymphoma. [Journal (On-line/Unpaginated)]

Full text available as:



Introduction: Orbital lymphoma is a rare presentation of extranodal non-Hodgkin's lymphoma, accounting for less than 1% of the total. The role of radiotherapy in its management is well-established. This is a report of a case of orbital lymphoma Materials and Methods: Clinical records and pathologic material of a patient woman of 62 age treated with local radiotherapy for localized orbital lymphoma. Treatment consisted of 36 Gy in 1.8-Gy fractions of irradiation using 6-MV photons with complex treatment planning for retrobulbar lesions. Median follow-up was 18 months Results: Local control was 100%. Cataracts was not observed in 8 of the treated eyes. Conclusion: In this case, localized orbital MALT lymphoma was well controlled with radiotherapy.

Item Type:Journal (On-line/Unpaginated)
Keywords:Eye, Non-Hodgkin's lymphoma, Orbit, Radiotherapy
Subjects:JOURNALS > Online Journal of Health and Allied Sciences
ID Code:6204
Deposited By: Kakkilaya Bevinje, Dr. Srinivas
Deposited On:19 Sep 2008 13:59
Last Modified:11 Mar 2011 08:57

References in Article

Select the SEEK icon to attempt to find the referenced article. If it does not appear to be in cogprints you will be forwarded to the paracite service. Poorly formated references will probably not work.

1. Isaacson PG, Wright D. Malignant lymphoma of mucosa-associated lymphoid tissue: a distinctive type of B-cell lymphoma. Cancer 1983;52:1410-1416

2. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasm: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1392.

3. Isaacson PG, Muller-Hermelink HK, Pris MA et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Jaffe ES, Harris NI, Stein H, et al. (eds): World Health Organization Classification of Tumors. Pathology and Genetics of Haematopoietic and Lymphoid Tissue. Lyon: IARC Press 2001; 157-160.

4. Raderer M, Streubel B, Woehrer S et al. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res 2005;11:3349-3352.

5. Aviles A, Nambo MJ, Neri N et al. Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial. Med Oncol 2005;22:57-62.

6. Wenzel C, Fiebiger W, Dieckmann K et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area. Cancer 2003;97:2236-2241.

7. Tsang RW, Gospodarowicz MK, Pintilie M et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 2003;21:4157-4164.

8. Tsang RW, Gospodarowicz MK, Pintilie M et al. Stage I and II MALT lymphoma: results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys 2001;50:1258-1264

9. Minehan K J, Martenson J A, Garrity J A, Kurtin P J, Banks P M, Chen M G, et al. Local control and complications after radiation therapy for primary orbital lymphoma: A case for low dose treatment. Int J Radiat Oncol Biol Phys 1991;20:791-6.

10. Chao C K, Lin H S, Devineni V R, Smith M. Radiation therapy for primary orbital lymphoma. Int J Radiat Oncol Biol Phys 1995;31:929-34.

11. Esik O, Ikeda H, Mukai K, Kaneko A. A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas. Radiother Oncol 1996;38:13-18.


Repository Staff Only: item control page